BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 28526919)

  • 21. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
    Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
    Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue transglutaminase autoantibodies in children with newly diagnosed type 1 diabetes are related to human leukocyte antigen but not to islet autoantibodies: A Swedish nationwide prospective population-based cohort study.
    Cerqueiro Bybrant M; Grahnquist L; Örtqvist E; Andersson C; Forsander G; Elding Larsson H; Lernmark Å; Ludvigsson J; Marcus C; Carlsson A; Ivarsson SA
    Autoimmunity; 2018 Aug; 51(5):221-227. PubMed ID: 30444426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
    Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
    Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
    Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
    Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of humoral autoimmunity in first-degree relatives of Mexican type 1 diabetes patients.
    Segovia-Gamboa NC; Rodríguez-Arellano ME; Muñoz-Solís A; Retana-Jiménez JE; Vargas-Ayala G; Granados J; Jiménez-Sánchez M; Sanchez-Torres C
    Acta Diabetol; 2018 Dec; 55(12):1275-1282. PubMed ID: 30306407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study.
    Long AE; Wilson IV; Becker DJ; Libman IM; Arena VC; Wong FS; Steck AK; Rewers MJ; Yu L; Achenbach P; Casas R; Ludvigsson J; Williams AJK; Gillespie KM
    Diabetologia; 2018 Jun; 61(6):1484-1490. PubMed ID: 29532109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity.
    Hermann R; Laine AP; Veijola R; Vahlberg T; Simell S; Lähde J; Simell O; Knip M; Ilonen J
    Diabetologia; 2005 Sep; 48(9):1766-75. PubMed ID: 16025255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
    Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population.
    Kukko M; Kimpimäki T; Korhonen S; Kupila A; Simell S; Veijola R; Simell T; Ilonen J; Simell O; Knip M
    J Clin Endocrinol Metab; 2005 May; 90(5):2712-7. PubMed ID: 15872335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes.
    Mäkinen A; Härkönen T; Ilonen J; Knip M;
    Eur J Endocrinol; 2008 Jul; 159(1):19-26. PubMed ID: 18573919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.
    Maziarz M; Hagopian W; Palmer JP; Sanjeevi CB; Kockum I; Breslow N; Lernmark Å; ; ;
    Genes Immun; 2015 Dec; 16(8):541-51. PubMed ID: 26513234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and
    Gorus FK; Balti EV; Messaaoui A; Demeester S; Van Dalem A; Costa O; Dorchy H; Mathieu C; Van Gaal L; Keymeulen B; Pipeleers DG; Weets I;
    Diabetes Care; 2017 Aug; 40(8):1065-1072. PubMed ID: 28701370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
    Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
    Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.
    Ilonen J; Lempainen J; Hammais A; Laine AP; Härkönen T; Toppari J; Veijola R; Knip M;
    Pediatr Diabetes; 2018 Mar; 19(2):284-292. PubMed ID: 28597949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood Diabetes in Finland Study Group.
    Kimpimäki T; Kulmala P; Savola K; Vähäsalo P; Reijonen H; Ilonen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1126-32. PubMed ID: 10720050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin VNTR I/III genotype is associated with autoantibodies against glutamic acid decarboxylase in newly diagnosed type 1 diabetes.
    Rajasalu T; Haller K; Salur L; Kisand K; Tillmann V; Schlosser M; Uibo R
    Diabetes Metab Res Rev; 2007 Oct; 23(7):567-71. PubMed ID: 17461431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progression to type 1 diabetes and autoantibody positivity in relation to HLA-risk genotypes in children participating in the ABIS study.
    Gullstrand C; Wahlberg J; Ilonen J; Vaarala O; Ludvigsson J
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):182-90. PubMed ID: 18331414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unmethylated Insulin as an Adjunctive Marker of Beta Cell Death and Progression to Type 1 Diabetes in Participants at Risk for Diabetes.
    Simmons KM; Fouts A; Pyle L; Clark P; Dong F; Yu L; Usmani-Brown S; Gottlieb P; Herold KC; Steck AK;
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between Ljungan virus antibodies, HLA-DQ8, and insulin autoantibodies in newly diagnosed type 1 diabetes children.
    Nilsson AL; Vaziri-Sani F; Andersson C; Larsson K; Carlsson A; Cedervall E; Jönsson B; Neiderud J; Elding Larsson H; Ivarsson SA; Lernmark Å
    Viral Immunol; 2013 Jun; 26(3):207-15. PubMed ID: 23682738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.